XOStem Biosciences has filed a notice of an exempt offering of securities to raise $1,571,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, XOStem Biosciences is raising $1,571,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Alex Mcaulay played a key role…